Entrada Therapeutics (TRDA) stock: insider trades, news & valuation
Strong buying
Close · Oct 9, 2026
$5.67
+2.5% on the day
-16.5% over 12 months
52-week range $5.38 – $16.03
Share price and insider trades
TRDA closeInsider buyInsider sale
Bought, 12 months$1.6M
Sold, 12 months$15.1M
Insiders buying3
Insiders selling12
Entrada Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $1.6M and 12 sold $15.1M of TRDA stock on the open market.
Get emailed when insiders cluster-buy stocks like TRDA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
TRDA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $10.3M | 33 |
| Q2 2026 | $29K | 1 | $661K | 3 |
| Q1 2026 | — | 0 | $508K | 5 |
| Q4 2025 | $1.6M | 16 | $3.6M | 3 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.0×Last 5 sessions
Insiders' paper profit−$442KOn all tracked purchases -26.9%
Summary
Over the past 12 months, 3 Entrada Therapeutics, Inc. insiders reported open-market purchases totaling $1.6M, while 12 insiders reported sales totaling $15.1M. Among insiders with enough purchase history to measure, Felix Baker (10% Owner) has the highest Insider Score at 55. 9 of 44 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 9SEC | Bioventures 2018 (b), L.p. Mpm10% Owner | Sell | 192,5003,913,952 held (−5%) | $7.41 | $1.4M | -23.5% | — |
| Sep 9SEC | Mpm Bioventures 2018 Gp Llc10% Owner | Sell | 192,5003,913,952 held (−5%) | $7.41 | $1.4M | -23.5% | — |
| Sep 9SEC | Bioventures 2018 (b), L.p. Mpm10% Owner | Sell | 38,5004,106,452 held (−1%) | $7.11 | $274K | -20.3% | — |
| Sep 9SEC | Mpm Bioventures 2018 Gp Llc10% Owner | Sell | 38,5004,106,452 held (−1%) | $7.11 | $274K | -20.3% | — |
| Sep 9SEC | Bioventures 2018 (b), L.p. Mpm10% Owner | Sell | 28,8373,885,115 held (−1%) | $7.13 | $206K | -20.5% | — |
| Sep 9SEC | Mpm Bioventures 2018 Gp Llc10% Owner | Sell | 28,8373,885,115 held (−1%) | $7.13 | $206K | -20.5% | — |
| Sep 3SEC | Mpm Bioventures 2014 Gp Llc10% Owner | Sell | 32,2634,144,952 held (−1%) | $7.17 | $231K | -20.9% | — |
| Sep 3SEC | Mpm Bioventures 2018 Llc10% Owner | Sell | 32,2634,144,952 held (−1%) | $7.17 | $231K | -20.9% | — |
| Sep 3SEC | Mpm Bioventures 2014 Gp Llc10% Owner | Sell | 29,0884,202,346 held (−1%) | $7.06 | $205K | -19.7% | — |
| Sep 3SEC | Mpm Bioventures 2018 Llc10% Owner | Sell | 29,0884,202,346 held (−1%) | $7.06 | $205K | -19.7% | — |
| Sep 3SEC | Mpm Bioventures 2014 Gp Llc10% Owner | Sell | 25,1314,177,215 held (−1%) | $7.19 | $181K | -21.1% | — |
| Sep 3SEC | Mpm Bioventures 2018 Llc10% Owner | Sell | 25,1314,177,215 held (−1%) | $7.19 | $181K | -21.1% | — |
| Aug 31SEC | Bioventures 2014 (b), L.p. Mpm10% Owner | Sell | 44,2594,231,434 held (−1%) | $6.99 | $309K | -18.9% | — |
| Aug 31SEC | Mpm Bioventures 2018 Llc10% Owner | Sell | 44,2594,231,434 held (−1%) | $6.99 | $309K | -18.9% | — |
| Aug 31SEC | Bioventures 2014 (b), L.p. Mpm10% Owner | Sell | 38,9224,279,426 held (−1%) | $7.20 | $280K | -21.3% | — |
| Aug 31SEC | Mpm Bioventures 2018 Llc10% Owner | Sell | 38,9224,279,426 held (−1%) | $7.20 | $280K | -21.3% | — |
| Aug 31SEC | Bioventures 2014 (b), L.p. Mpm10% Owner | Sell | 3,7334,275,693 held (−0%) | $7.01 | $26K | -19.1% | — |
| Aug 31SEC | Mpm Bioventures 2018 Llc10% Owner | Sell | 3,7334,275,693 held (−0%) | $7.01 | $26K | -19.1% | — |
| Aug 26SEC | Todd Foley10% Owner | Sell | 26,5224,332,917 held (−1%) | $7.54 | $200K | -24.8% | — |
| Aug 26SEC | Mpm Bioventures 2018 Llc10% Owner | Sell | 26,5224,332,917 held (−1%) | $7.54 | $200K | -24.8% | — |
| Aug 26SEC | Todd Foley10% Owner | Sell | 21,6234,359,439 held (−0%) | $7.34 | $159K | -22.8% | — |
| Aug 26SEC | Mpm Bioventures 2018 Llc10% Owner | Sell | 21,6234,359,439 held (−0%) | $7.34 | $159K | -22.8% | — |
| Aug 26SEC | Todd Foley10% Owner | Sell | 14,5694,318,348 held (−0%) | $7.06 | $103K | -19.7% | — |
| Aug 26SEC | Mpm Bioventures 2018 Llc10% Owner | Sell | 14,5694,318,348 held (−0%) | $7.06 | $103K | -19.7% | — |
| Aug 10SEC | Kush ParmarDirector | Sell | 92,4442,691,337 held (−3%) | $7.00 | $647K | -19.0% | — |
| Aug 10SEC | Kush ParmarDirector | Sell | 52,3172,783,781 held (−2%) | $6.85 | $358K | -17.2% | — |
| Aug 10SEC | Scott M Rocklage10% Owner | Sell | 52,3172,783,781 held (−2%) | $6.85 | $358K | -17.2% | — |
| Aug 10SEC | Kush ParmarDirector | Sell | 10,4942,836,098 held (−0%) | $7.00 | $73K | -19.0% | — |
| Aug 10SEC | Scott M Rocklage10% Owner | Sell | 10,4942,836,098 held (−0%) | $7.00 | $73K | -19.0% | — |
| Aug 3SEC | Kush ParmarDirector | Sell | 114,7562,848,310 held (−4%) | $6.93 | $795K | -18.2% | — |
| Aug 3SEC | Scott M Rocklage10% Owner | Sell | 114,7562,848,310 held (−4%) | $6.93 | $795K | -18.2% | — |
| Aug 3SEC | Kush ParmarDirector | Sell | 1,7182,846,592 held (−0%) | $6.85 | $12K | -17.2% | — |
| Aug 3SEC | Scott M Rocklage10% Owner | Sell | 1,7182,846,592 held (−0%) | $6.85 | $12K | -17.2% | — |
| May 21SEC | Bernhardt G ZeiherDirector | Buy | 5,000new position | $5.86 | $29K | -3.2% | — |
| May 4SEC | Natarajan SethuramanPresident | Sell Plan | 25,907216,317 held (−11%) | $15.39 | $399K | -63.2% | — |
| May 4SEC | Nathan J DowdenCOO, President | Sell Plan | 15,000198,588 held (−7%) | $15.33 | $230K | -63.0% | — |
| Apr 2SEC | Kory James WentworthCFO | Sell Plan | 2,500119,010 held (−2%) | $12.95 | $32K | -56.2% | — |
| Mar 11SEC | Nathan J DowdenCOO, President | Sell Plan | 11,894198,588 held (−6%) | $13.05 | $155K | -56.6% | — |
| Mar 11SEC | Kory James WentworthCFO | Sell Plan | 11,388121,510 held (−9%) | $13.02 | $148K | -56.5% | — |
| Mar 11SEC | Kory James WentworthCFO | Sell Plan | 5,089132,898 held (−4%) | $13.00 | $66K | -56.4% | — |
| Mar 11SEC | Nathan J DowdenCOO, President | Sell Plan | 3,116210,482 held (−1%) | $13.02 | $41K | -56.5% | — |
| Mar 6SEC | Kory James WentworthCFO | Sell Plan | 7,988137,987 held (−5%) | $12.25 | $98K | -53.7% | — |
| Nov 24SEC | Felix Baker10% Owner | Buy | 13,3864,678,310 held (+0%) | $9.07 | $121K | -37.5% | 55 |
| Nov 24SEC | Felix Baker10% Owner | Buy | 13,0824,691,392 held (+0%) | $9.07 | $119K | -37.5% | 55 |
| Nov 24SEC | Kory James WentworthCFO | Sell Plan | 8,910110,026 held (−7%) | $9.98 | $89K | -43.2% | — |
| Nov 24SEC | Felix Baker10% Owner | Buy | 1,213380,152 held (+0%) | $9.07 | $11K | -37.5% | 55 |
| Nov 24SEC | Felix Baker10% Owner | Buy | 1,186381,338 held (+0%) | $9.07 | $11K | -37.5% | 55 |
| Nov 18SEC | Kush ParmarDirector | Sell | 200,0002,963,066 held (−6%) | $8.80 | $1.8M | -35.6% | — |
| Nov 18SEC | Ventures V, L.p. 5am10% Owner | Sell | 200,0002,963,066 held (−6%) | $8.80 | $1.8M | -35.6% | — |
| Nov 12SEC | Baker Bros. Advisors (Gp) Llc10% Owner | Buy | 80,8814,653,430 held (+2%) | $7.73 | $625K | -26.6% | — |
| Nov 12SEC | Baker Bros. Advisors (Gp) Llc10% Owner | Buy | 30,8794,572,549 held (+1%) | $7.54 | $233K | -24.8% | — |
| Nov 12SEC | Baker Bros. Advisors (Gp) Llc10% Owner | Buy | 25,3644,527,022 held (+1%) | $7.21 | $183K | -21.4% | — |
| Nov 12SEC | Baker Bros. Advisors (Gp) Llc10% Owner | Buy | 11,4944,664,924 held (+0%) | $7.95 | $91K | -28.7% | — |
| Nov 12SEC | Baker Bros. Advisors (Gp) Llc10% Owner | Buy | 11,7014,541,670 held (+0%) | $7.39 | $86K | -23.3% | — |
| Nov 12SEC | Baker Bros. Advisors (Gp) Llc10% Owner | Buy | 7,321377,899 held (+2%) | $7.73 | $57K | -26.6% | — |
| Nov 12SEC | Baker Bros. Advisors (Gp) Llc10% Owner | Buy | 2,9474,529,969 held (+0%) | $7.22 | $21K | -21.5% | — |
| Nov 12SEC | Baker Bros. Advisors (Gp) Llc10% Owner | Buy | 2,795370,578 held (+1%) | $7.54 | $21K | -24.8% | — |
| Nov 12SEC | Baker Bros. Advisors (Gp) Llc10% Owner | Buy | 2,296366,457 held (+1%) | $7.21 | $17K | -21.4% | — |
| Nov 12SEC | Baker Bros. Advisors (Gp) Llc10% Owner | Buy | 1,040378,939 held (+0%) | $7.95 | $8K | -28.7% | — |
| Nov 12SEC | Baker Bros. Advisors (Gp) Llc10% Owner | Buy | 1,059367,783 held (+0%) | $7.39 | $8K | -23.3% | — |
| Nov 12SEC | Baker Bros. Advisors (Gp) Llc10% Owner | Buy | 267366,724 held (+0%) | $7.22 | $2K | -21.5% | — |
Insiders at Entrada Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Baker Bros. Advisors (Gp) Llc10% Owner | $1.4M | — | Nov 12, 2025 | — |
| Kush ParmarDirector | — | $3.6M | Aug 10, 2026 | — |
| Bioventures 2018 (b), L.p. Mpm10% Owner | — | $1.9M | Sep 9, 2026 | — |
| Mpm Bioventures 2018 Gp Llc10% Owner | — | $1.9M | Sep 9, 2026 | — |
| Ventures V, L.p. 5am10% Owner | — | $1.8M | Nov 18, 2025 | — |
| Mpm Bioventures 2018 Llc10% Owner | — | $1.7M | Sep 3, 2026 | — |
| Scott M Rocklage10% Owner | — | $1.2M | Aug 10, 2026 | — |
| Felix Baker10% Owner | $262K | — | Nov 24, 2025 | 55 |
| Mpm Bioventures 2014 Gp Llc10% Owner | — | $617K | Sep 3, 2026 | — |
| Bioventures 2014 (b), L.p. Mpm10% Owner | — | $616K | Aug 31, 2026 | — |
| Todd Foley10% Owner | — | $462K | Aug 26, 2026 | — |
| Kory James WentworthCFO | — | $434K | Apr 2, 2026 | — |
| Nathan J DowdenCOO, President | — | $426K | May 4, 2026 | — |
| Natarajan SethuramanPresident | — | $399K | May 4, 2026 | — |
| Bernhardt G ZeiherDirector | $29K | — | May 21, 2026 | — |
TRDA stock: common questions
Are Entrada Therapeutics, Inc. insiders buying TRDA stock?
In the past 12 months, 3 insiders reported open-market purchases of TRDA worth $1.6M. The latest was Director Bernhardt G Zeiher bought $29K of TRDA at $5.86 — first open-market purchase in our records; opens a new position.
Are Entrada Therapeutics, Inc. insiders selling TRDA stock?
12 insiders reported sales worth $15.1M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is TRDA's 52-week range?
Over the past year TRDA has traded between $5.38 and $16.03. It last closed at $5.67 on Oct 9, 2026.